{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:33:42Z","timestamp":1769758422554,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670311"],"award-info":[{"award-number":["81670311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.yjmcc.2020.09.009","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T11:27:04Z","timestamp":1601292424000},"page":"82-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Glycogen synthase kinase-3\u03b2 inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction"],"prefix":"10.1016","volume":"149","author":[{"given":"Shuhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumra","family":"Komal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexiang","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinshou","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengna","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.009_bb0005","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1161\/STROKEAHA.111.635755","article-title":"Stroke and stroke care in China: huge burden, significant workload, and a national priority","volume":"42","author":"Liu","year":"2011","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.009_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.09.009_bb0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.009_bb0025","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1536\/ihj.13-388","article-title":"NLRP3 inflammasome as a novel player in myocardial infarction","volume":"55","author":"Takahashi","year":"2014","journal-title":"Int. Heart J."},{"issue":"20","key":"10.1016\/j.yjmcc.2020.09.009_bb0035","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction","volume":"117","author":"Abbate","year":"2008","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.2012.02517.x","article-title":"Increased interleukin-1beta levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"272","author":"Orn","year":"2012","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.09.009_bb0045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","article-title":"Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling trial [VCU-ART] pilot study)","volume":"105","author":"Abbate","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq017","article-title":"Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse","volume":"12","author":"Abbate","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.09.009_bb0055","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling trial (2) (VCU-ART2) pilot study]","volume":"111","author":"Abbate","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0060","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.ijcard.2013.12.078","article-title":"Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?","volume":"171","author":"Abbate","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"20","key":"10.1016\/j.yjmcc.2020.09.009_bb0065","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","article-title":"Targeting interleukin-1beta reduces leukocyte production after acute myocardial infarction","volume":"132","author":"Sager","year":"2015","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.009_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","article-title":"Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy","volume":"151","author":"Haq","year":"2000","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.09.009_bb0085","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCRESAHA.109.211482","article-title":"Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo","volume":"106","author":"Woulfe","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113302","article-title":"Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK\/GSK-3beta","volume":"329","author":"Liu","year":"2020","journal-title":"Exp. Neurol."},{"issue":"52","key":"10.1016\/j.yjmcc.2020.09.009_bb0095","doi-asserted-by":"crossref","first-page":"20900","DOI":"10.1073\/pnas.0808315106","article-title":"Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload","volume":"105","author":"Matsuda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.09.009_bb0100","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.107.160614","article-title":"Inhibition of glycogen synthase kinase 3beta during heart failure is protective","volume":"101","author":"Hirotani","year":"2007","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-010-6234-z","article-title":"Mitochondria and GSK-3beta in cardioprotection against ischemia\/reperfusion injury","volume":"24","author":"Miura","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.182.1.547","article-title":"Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1\/2","volume":"182","author":"Rehani","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0115","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2010.12.039","article-title":"Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis","volume":"55","author":"Coant","year":"2011","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0120","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.38993","article-title":"Lupus nephritis: glycogen synthase kinase 3beta promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice","volume":"67","author":"Zhao","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.intimp.2018.12.042","article-title":"Inhibition of GSK-3beta alleviates cerebral ischemia\/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy","volume":"68","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.009_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jnen\/nly015","article-title":"GSK-3beta\/mTORC1 couples synaptogenesis and axonal repair to reduce hypoxia ischemia-mediated brain injury in neonatal rats","volume":"77","author":"Xiong","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"14","key":"10.1016\/j.yjmcc.2020.09.009_bb0135","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.09.009_bb0140","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.009_bb0145","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3beta inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"7081","key":"10.1016\/j.yjmcc.2020.09.009_bb0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature."},{"issue":"5876","key":"10.1016\/j.yjmcc.2020.09.009_bb0160","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0165","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1038\/ncomms11929","article-title":"ASC filament formation serves as a signal amplification mechanism for inflammasomes","volume":"7","author":"Dick","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.009_bb0170","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.cdd.4402194","article-title":"The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation","volume":"14","author":"Fernandes-Alnemri","year":"2007","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.009_bb0175","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1002\/jcp.27434","article-title":"Laurus nobilis leaf extract controls inflammation by suppressing NLRP3 inflammasome activation","volume":"234","author":"Lee","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.009_bb0180","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","volume":"2017","author":"Mancinelli","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.009_bb0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1074248417702890","article-title":"The highly selective Caspase-1 inhibitor VX-765 provides additive protection against myocardial infarction in rat hearts when combined with a platelet inhibitor","volume":"22","author":"Yang","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"1\u20133","key":"10.1016\/j.yjmcc.2020.09.009_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2008.02.075","article-title":"Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763","volume":"586","author":"Nemoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.yjmcc.2020.09.009_bb0200","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.7150\/thno.36505","article-title":"Inhibition of HSP90beta improves lipid disorders by promoting mature SREBPs degradation via the ubiquitin-proteasome system","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0205","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbrc.2020.02.165","article-title":"Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells","volume":"525","author":"Inoue","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114813","article-title":"Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt\/beta-catenin signaling","volume":"386","author":"Zhao","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0215","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2119\/molmed.2012.00180","article-title":"Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice","volume":"18","author":"Adamowicz","year":"2012","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCRESAHA.111.243170","article-title":"Inflammation in myocardial diseases","volume":"110","author":"Marchant","year":"2012","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.09.009_bb0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Mechanisms of disease: myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"New Engl J Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.009_bb0230","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0735-1097(01)01591-1","article-title":"Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling","volume":"38","author":"Hwang","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yexmp.2016.09.002","article-title":"The role of cardiac fibroblasts in post-myocardial heart tissue repair","volume":"101","author":"Chistiakov","year":"2016","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","article-title":"The role of IL-1 in the pathogenesis of heart disease","volume":"57","author":"Bujak","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cmet.2017.06.018","article-title":"Inflammasomes on the crossroads of innate immune recognition and metabolic control","volume":"26","author":"Prochnicki","year":"2017","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.009_bb0250","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2008.04.059","article-title":"Macrophage roles following myocardial infarction","volume":"130","author":"Lambert","year":"2008","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.009_bb0260","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1159\/000374048","article-title":"Activation in M1 but not M2 macrophages contributes to cardiac Remodeling after myocardial infarction in rats: a critical role of the calcium sensing receptor\/NRLP3 Inflammasome","volume":"35","author":"Liu","year":"2015","journal-title":"Cellular physiology and biochemistry\u202f: international journal of experimental cellular physiology, biochemistry, and pharmacology."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0265","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1248\/bpb.b18-00369","article-title":"Role of NLRP3 Inflammasome in cardiac inflammation and Remodeling after myocardial infarction","volume":"42","author":"Takahashi","year":"2019","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvt130","article-title":"A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0280","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2741\/1304","article-title":"NF-kappaB action in sepsis: the innate immune system and the heart","volume":"9","author":"Brown","year":"2004","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0285","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardiores.2006.09.011","article-title":"Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response","volume":"72","author":"Boyd","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"18","key":"10.1016\/j.yjmcc.2020.09.009_bb0290","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/138161211796390976","article-title":"Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure","volume":"17","author":"Aoyagi","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.009_bb0295","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/519528","article-title":"Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication","volume":"2014","author":"Lindner","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"49","key":"10.1016\/j.yjmcc.2020.09.009_bb0305","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic inhibition of the NLRP3 Inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.009_bb0315","doi-asserted-by":"crossref","first-page":"H1883","DOI":"10.1152\/ajpheart.00514.2007","article-title":"Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse","volume":"293","author":"Banerjee","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0320","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"31","key":"10.1016\/j.yjmcc.2020.09.009_bb0325","doi-asserted-by":"crossref","first-page":"25929","DOI":"10.1021\/acsami.7b08777","article-title":"Graphene sheet-induced global maturation OF Cardiomyocytes derived from human induced pluripotent stem cells","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.009_bb0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00204-019-02403-y","article-title":"Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes","volume":"93","author":"Cai","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0335","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41598-018-19822-z","article-title":"GSK3beta modulates NF-kappaB activation and RelB degradation through site-specific phosphorylation of BCL10","volume":"8","author":"Abd-Ellah","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.onc.1209004","article-title":"Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0345","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8027537","article-title":"Anti-inflammatory effects of Artemisia leaf extract in mice with contact dermatitis In vitro and In vivo","volume":"2016","author":"Yun","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yjmcc.2020.09.009_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6054069","article-title":"Artemisia extract suppresses NLRP3 and AIM2 Inflammasome activation by inhibition of ASC phosphorylation","volume":"2018","author":"Kwak","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.009_bb0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm.4016","article-title":"In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity","volume":"22","author":"Sagoo","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.009_bb0360","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1189\/jlb.3HI0814-371RR","article-title":"Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization","volume":"97","author":"Lin","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.009_bb0365","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9440(10)63154-9","article-title":"Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction","volume":"164","author":"Dewald","year":"2004","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:31:58Z","timestamp":1758313918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820302893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":73,"alternative-id":["S0022282820302893"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen synthase kinase-3\u03b2 inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}